Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Royal DSM Sells Half of Antibiotics Unit to Sinochem

publication date: Dec 17, 2010
Royal DSM NV sold 50% of its anti-infectives unit to Sinochem Group for $291 million, forming a JV between the two companies. Sinochem will use its extensive distribution network to market the JV’s antibiotics in China. DSM claims to be the global leader in beta-lactam antibiotics, the largest selling class in the world that includes penicillin derivatives such as cephalosporins. More details....

Stock Symbol: (XAMS: DSM)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital